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Bijata et al. examine a signaling module
involving the 5-HT7 receptor (5-HT7R),
matrix metalloproteinase 9 (MMP-9), the
hyaluronan receptor CD44, and the small
GTPase Cdc42. Stimulation of 5-HT7R
results in MMP-9 activation, which, in
turn, cleaves CD44. This results in local
detachment from the ECM, thus
facilitating spine elongation via 5-HT7R/
Cdc42 signaling.
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Rewiring of synaptic circuitry pertinent to memory
formation has been associated with morphological
changes in dendritic spines and with extracellular
matrix (ECM) remodeling. Here, we mechanistically
link these processes by uncovering a signaling
pathway involving the serotonin 5-HT7 receptor
(5-HT7R), matrix metalloproteinase 9 (MMP-9), the
hyaluronan receptor CD44, and the small GTPase
Cdc42. We highlight a physical interaction between
5-HT7R and CD44 (identified as an MMP-9 substrate
in neurons) and find that 5-HT7R stimulation in-
creases local MMP-9 activity, triggering dendritic
spine remodeling, synaptic pruning, and impairment
of long-term potentiation (LTP). The underlying
molecular machinery involves 5-HT7R-mediated
activation of MMP-9, which leads to CD44 cleavage
followed by Cdc42 activation. One important physio-
logical consequence of this interaction includes an
increase in neuronal outgrowth and elongation of
dendritic spines, which might have a positive effect
on complex neuronal processes (e.g., reversal
learning and neuronal regeneration).
INTRODUCTION
Dendritic spines that host excitatory synaptic contacts can un-
dergo morphological changes in response to stimuli that trigger
long-term alterations in transmission efficacy. This structural re-
modeling leads to neural network rewiring on a larger scale,
which is a commonly perceived substrate of learning and mem-
ory formation and, in some cases of pathological changes, in theCe
This is an open access article under the CC BY-Nbrain (Sala and Segal, 2014). This process is regulated by
signaling pathways that engage the neurotransmitter serotonin
(5-hydroxytryptamine [5-HT]) and the extracellular matrix
(ECM) (Udo et al., 2005; Dityatev et al., 2010). However, the
mechanism underlying the molecular interactions between the
ECM and serotonin-mediated signaling in neurons in situ has re-
mained unknown.
The serotonin receptor subtype 5-HT7 has recently been re-
ported to play a significant role in pathological forms of synaptic
plasticity, such as those associated with anxiety and depression
(Hedlund, 2009; Matthys et al., 2011). At the molecular level,
5-HT7 receptors (5-HT7Rs) prompt the formation of cyclic
AMP (cAMP) by activating adenylyl cyclase via the stimulatory
Gas protein (Norum et al., 2003). 5-HT7R-mediated activation
of the heteromeric Ga12 protein results in selective activation
of small guanosine triphosphatases (GTPases) of the Rho family,
which, in turn, triggers pronounced changes in cellular
morphology, including synaptogenesis (Kvachnina et al., 2005;
Kobe et al., 2012).
Among numerous ECM components and modifiers that play a
part in long-termmemory and synaptic plasticity, matrix metallo-
proteinase 9 (MMP-9) has recently emerged as a key molecule
(Huntley, 2012). MMP-9 may contribute to dynamic remodeling
of the ECM via cleaving ECM components, such as laminin
and aggrecan, and cell adhesion molecules (Dityatev et al.,
2010; Ethell and Ethell, 2007). At the same time,MMP-9 signaling
has been shown to contribute to the formation and maintenance
of dendritic spines (Wang et al., 2008; Michaluk et al., 2011; Sze-
pesi et al., 2013, 2014) and, possibly, dendritic protrusions
associated with neuropsychiatric disorders (for a review, see
Stawarski et al., 2014a). Notably, elevated levels of MMP-9
were found in the blood of patients with clinical depression
(Rybakowski et al., 2013).
Notwithstanding its apparent significance, the causal link be-
tween MMP-9 activity and structural plasticity has remainedll Reports 19, 1767–1782, May 30, 2017 ª 2017 The Authors. 1767
C-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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poorly understood. Several cell adhesion proteins have been
proposed as the substrates of MMP-9 in neurons (Michaluk
et al., 2007; Bajor et al., 2012), but their roles in the structural
plasticity of dendritic spines are yet to be ascertained. Here we
identify the transmembrane protein CD44, which connects the
neuronal cytoskeleton to the ECM, as a previously unknown
neuronal MMP-9 substrate. CD44 is a major receptor for hyalur-
onan, which is the main component of the neural ECM influ-
encing both structural and functional aspects of neuronal
plasticity (Kochlamazashvili et al., 2010). The extracellular N-ter-
minal CD44 domain is responsible for binding hyaluronic acid,
osteopontin, collagen, laminin, and fibronectin (Carter and Way-
ner, 1988;Weber et al., 1996). TheC-terminal cytoplasmic region
interacts with different cytoskeleton-associated proteins, such
as ankyrin (Kalomiris and Bourguignon, 1988) and ezrin/radixin/
moesin (ERM) proteins (Duterme et al., 2009). CD44-mediated
signaling also modulates the activity of small Rho GTPases
(Bourguignon et al., 2005). In neurons, GTPases of the Rho family
play a pivotal role in spino- and synaptogenesis (Jontes and
Smith, 2000). One omnipresent member of the RhoGTPase fam-
ily acting as a positive regulator of filopodium formation, neurite
outgrowth, and growth cone protrusion is Cdc42 (Brown et al.,
2000). Cdc42 has also emerged as an important modulator of
structural plastic changes in dendrites and dendritic spines
(Newey et al., 2005).
In the present study, we establish a causal link between
5-HT7R-mediated signaling and extracellular cleavage of CD44
by MMP-9, which, in turn, engages Cdc42 to regulate synapto-
genesis, LTP, and the structural plasticity of dendritic spines.
RESULTS
5-HT7R Stimulation Triggers Dendritic Spine
Morphogenesis, which Requires MMP-9 Activity and
Depends on Cdc42
To test whether and how 5-HT7R activation engages MMP-9-
dependent dendritic spine morphogenesis, we monitored spine
morphology using the length over head width ratio as a scale-
free parameter in real time in dissociated hippocampal cultures
expressing red fluorescent protein (RFP). The 5-HT7R agonist
5-carboxamidotryptamine (5-CT) (10 mM, 20 min) triggered aFigure 1. Changes in Spine Shape after 5-HT7R Stimulation Depend o
(A) RFP-transfected hippocampal WT neurons captured during live imaging unde
aaMMP-9. The arrows indicate the locations of spines that underwent structural
(B) Hippocampal neurons from 5-HT7R KO mice and MMP-9 KO mice stimulate
(C) Hippocampal neurons co-transfected with shRNA against CD44 or scramble
(D) Quantification of changes in the length/head width ratio of dendritic spines 2
ncells/spines = 25/560) increases the ratio compared with control neurons (0.02 ± 0
(0.01 ± 0.03, ncells/spines = 16/326). Treatment with aaMMP-9 caused spine elon
MMP-9 KO neurons with 5-CT did not influence spine morphology (5-HT7R KO
ncells/spines = 19/468; MMP-9 KO + 5-CT, 0.01 ± 0.02, ncells/spines = 12/429; MMP
with Cdc42 inhibitor prevented the 5-CT changes and aaMMP-9mediated change
8/404). 5-HT7R stimulation in neurons transfected with CD44 shRNA did not infl
neurons (0.0 ± 0.02, ncells/spines = 11/391). Spine elongation after 5-CT treatmen
neurons (0.12 ± 0.04, ncells/spines = 13/417). A significantly higher length/head widt
with 5-CT compared with non-stimulated cells (0.02 ± 0.02, ncells/spines = 10/402). T
are expressed as mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001.).
See also Figure S1.prominent elongation of dendritic spines shortly after stimula-
tion (Figure 1A; see Figure 1D for a statistical summary),
consistent with previous observations (Kvachnina et al.,
2005). These changes were receptor-specific because they
were blocked by the high-affinity 5-HT7R antagonist SB
269970 (Figures 1A and 1D). Similar spine elongation was ob-
served after application of auto-activating MMP-9 (aaMMP-9,
400 ng/ml, 20 min) (Figures 1A and 1D). In contrast, no spine
elongation was detected in cultures prepared from MMP-9
knockout (KO) (Ducharme et al., 2000) and 5-HT7R KO (Hed-
lund et al., 2003) mice (Figures 1B and 1D), confirming specific
involvement of 5-HT7R/MMP-9 signaling in dendritic spine
changes. Noteworthy is that the increase in the spine length
obtained after application of aaMMP-9 or upon 5-HT7R
stimulation was accompanied by decreased spine head width
(Figure S1B).
We have previously suggested, based on sample comparison
data, that the small GTPase Cdc42 is a downstream effector of
5-HT7R signaling involved in neurite outgrowth (Kvachnina
et al., 2005). Strikingly, pretreatment of neurons with the specific
Cdc42 inhibitor ZCL278 (Friesland et al., 2013) completely pre-
vented dendritic spine elongation in response to either 5-HT7R
stimulation or aaMMP-9 treatment (Figures S1A and 1D).
Because MMP-9 is a known ECM modifier (Dityatev et al.,
2010; Huntley, 2012; Ethell and Ethell, 2007), we asked whether
the ECM can also be involved. For that, we focused on CD44,
the receptor for a major ECM component, hyaluronan, connect-
ing the ECM with the intracellular signaling pathway involved in
activation of the small Rho GTPases. Silencing of neuronal
CD44 expression via specific short hairpin RNAs (shRNAs) (Sku-
pien et al., 2014) abrogated the 5-HT7R stimulation-induced
elongation of dendritic spines, whereas neurons transfected
with a plasmid encoding a scrambled shRNA displayed
elongation similar to that in non-transfected neurons (Figures
1C and 1D).
We next sought to test whether 5-HT7R activation induced
morphological alterations in organized brain tissue and whether
dendritic spines undergoing such changes, if any, indeed repre-
sent functional synapses. We therefore turned to the preparation
of organotypic hippocampal slices and held imaged pyramidal
cells in whole-cell mode to probe their individual dendritic spinesn MMP-9, CD44, and Cdc42
r control conditions and after treatment with 5-CT, SB 269970 (SB) + 5-CT, and
plasticity.
d with 5-CT.
shRNA and stimulated with 5-CT.
0 min after stimulation with 5-CT or aaMMP-9. 5-CT application (0.12 ± 0.03,
.02, ncells/spines = 19/392). Treatment with SB269970 abolished these changes
gation (0.16 ± 0.05, ncells/spines = 15/408). Incubation of 5-HT7R KO neurons or
+ 5-CT, 0.05 ± 0.03, ncells/spines = 26/447; 5-HT7R KO control, 0.06 ± 0.04,
-9 KO control, 0.02 ± 0.02, ncells/spines = 15/631). Pretreatment of the neurons
s, respectively (0.02 ± 0.03, ncells/spines = 9/361 and0.01 ± 0.03, ncells/spines =
uence spine shape (0.00 ± 0.03, ncells/spines = 17/490) compared with control
t in neurons transfected with scramble shRNA was similar to non-transfected
h ratio was observed in neurons transfected with scramble shRNA and treated
he quantification of spines was done using a cell as the statistical unit. The data
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Figure 2. Probing Synaptic Function and 5-CT Effects at Dendritic Spines in Organotypic Hippocampal Slices
(A) Monitoring of dendritic spine morphology in control conditions and after 5-CT application as indicated. Red arrows, examples of spines with altered
morphology after 20 min in 5-CT.
(B) Changes in spine shape over 20 min under control conditions and after 5-CT application as indicated. Columns ± error bars, mean ± SEM; *p < 0.03.
(C) Two-photon spot uncaging of glutamate triggers postsynaptic Ca2+ entry at an immediately adjacent dendritic spine.
(C1) Dendritic fragment of interest (example, Alexa channel) with uncaging (UC) spot, line scan positioning (dotted line), and three regions of interests (1, 2, and
3—immediate spine, dendritic stem, and neighboring spine, respectively) as indicated.
(C2) Postsynaptic Ca2+ transients (top, line scan; bottom, traces; as indicated) triggered by glutamate UC (onset shown by the dotted line) originate in the
immediately adjacent spine (1) followed by rises in neighboring dendritic compartments (2 and 3) as indicated.
(D) Probing postsynaptic glutamatergic responses in dendritic spines that undergo 5-CT-inducedmorphological changes (example). Top: dendritic fragment with
the spine of interest before and 20 min after 5-CT application as indicated (example, Alexa channel). Red dot, position of spot uncaging. Bottom: an electrical
response in the postsynaptic spine to glutamate spot uncaging (voltage-clamp at 70 mV).with two-photon spot uncaging of extracellular glutamate. First
we confirmed that, with these experimental settings, 5-CT
induced a significant increase in the spine elongation factor (Fig-
ures 2A and 2B), which was fully consistent with that in the
experiments in dissociated cultures (Figure 1). The average
quantitative effect was somewhat smaller (albeit statistically sig-
nificant) than that in cultured cells, most likely because of the
whole-cell pipette dialysis, which could potentially dilute cellular
metabolites involved in the morphogenesis. Reassuringly, 2.9%
of analyzed spines increased their elongation factor by more
than 3-fold after 5-CT treatment, whereas, in control experi-
ments, this fraction (because of baseline shape fluctuations)
was only 0.8%.
Second, we used postsynaptic Ca2+ imaging to confirm that
our uncaging protocol triggers Ca2+ responses in individual den-
dritic spine heads rather than in dendrites in bulk (Figure 2C). In1770 Cell Reports 19, 1767–1782, May 30, 2017these tests, the evoked Ca2+ signal onset in the spine head was
in advance of that in the dendrite, thus indicating the spine head
origin of the Ca2+ entry, as shown by us earlier in experiments
involving optical quantal analysis (Boddum et al., 2016). Finally,
we found that, in all tested spines that underwent visible 5-CT-
induced changes, glutamate uncaging evoked a robust postsyn-
aptic electrical response (Figure 2D) entirely consistent with the
endogenously evoked excitatory postsynaptic currents (EPSCs)
documented routinely in similar settings (Rusakov and Fine,
2003).
These experiments suggest that 5-HT7R, MMP-9, CD44, and
Cdc42 represent components of a molecular cascade required
for the triggering of morphological changes in dendritic spines
and that, in all likelihood, these modified spines represent func-
tional synapses. Therefore, we next focused on the underlying
molecular machinery.
Figure 3. Interaction between 5-HT7R and
CD44 in Neuroblastoma N1E-115 Cells
(A and B) CoIP of recombinant HA-tagged
5-HT7Rs (HA-5-HT7R) and CD44-GFP in N1E
cells. A mixture of cells that expressed each indi-
vidual protein (mix) or cells that co-expressed both
proteins (co-expression) were subjected to immu-
noprecipitation (IP) with anti-HA (A) or anti-GFP (B)
antibody, followed by western blot (WB) analysis
with anti-GFP (left) and anti-HA (right) antibodies.
Top: the expression of proteins before IP (Lysate
w/o IP). Bottom: the expression of proteins after IP.
The results are representative of at least four in-
dependent experiments.
(C) Specific interaction between 5-HT7R tagged
with CFP (5-HT7R-CFP) and CD44-YFP. Cells that
co-expressed 5-HT7R-CFP and CD44-YFP were
analyzed using the lux-FRETmethod after confocal
microscopy. Top: distribution of 5-HT7R-CFP
(donor), CD44-YFP (acceptor), andmerged images
calculated by linear unmixing of the fluorescence
emission spectra. Bottom: the apparent FRET ef-
ficiency (EfDA). A representative cell is shown. See
also Figures S2 and S3.
(D) Quantification of FRET efficiencies (EfDA) be-
tween 5-HT7R-CFP and CD44-YFP (EfDA =
11.51% ± 1.12%, nCell = 7) as well as CD86-CFP
and CD86-YFP (EfDA = 7.37% ± 0.22%, p = 0.0029,
nCell = 7). Data represent mean ± SEM (n = 7,
**p < 0.05, Student’s t test).Recombinant 5-HT7Rs and CD44 Interact on the
Nanoscale
Both 5-HT7R and CD44 are integral membrane proteins residing
at the plasma membrane. Therefore, we first investigated
whether the signaling described above involves direct interac-
tions between 5-HT7Rs and CD44. In co-immunoprecipitation
(coIP) experiments performed in neuroblastoma N1E-115Cell Rcells co-expressing hemagglutinin (HA)-
tagged 5-HT7Rs (HA-5-HT7Rs) and
GFP-tagged CD44 (CD44-GFP), CD44 in-
teracted with HA-5-HT7R (Figures 3A and
3B). The specificity of coIP was confirmed
by analysis in cells expressing either HA-
5-HT7Rs only, CD44-GFP only, or a
mixture of these cells performed before
lysis (Figures 3A and 3B).
CoIP requires solubilization and con-
centration of the membrane proteins,
which can result in artificial aggregation
of receptors (Harrison and van der Graaf,
2006). To overcome this limitation and
to analyze the oligomerization behavior
of 5-HT7Rs and CD44 in living cells,
we applied a fluorescence resonance en-
ergy transfer (FRET)-based approach.
FRET efficiencies between CFP-labeled
5-HT7Rs (5-HT7R-CFP, donor) and yel-
low fluorescent protein (YFP)-labeled
CD44 (CD44-YFP, acceptor) were mea-sured in living N1E-115 using the linear unmixing (lux)-FRET
method; this approach is capable of detecting the physical prox-
imity of individual molecules on the nanoscale (Wlodarczyk et al.,
2008). These experiments revealed that 5-HT7R-CFP and CD44-
YFP were co-localized at the plasmamembrane (Figure 3C). The
donor molar fraction xD, which indicates the ratio between donor
and acceptor molecules, was in the range of 0.5, demonstratingeports 19, 1767–1782, May 30, 2017 1771
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that both proteins were expressed at similar concentrations (Fig-
ure S2). The lux-FRET analysis revealed high apparent FRET
efficiency, EfDA (EfDA = 11.51% ± 1.12%), for 5-HT7R-CFP and
CD44-YFP. In contrast, cells expressing both CD86-CFP and
CD86-YFP, which have been considered monomeric (Dorsch
et al., 2009), showed much lower EfDA values (Figure 3D). More-
over, the EfDA values of CD86 showed a linear dependence on
the relative expression level (Figure S3A), pointing to a random
rather than a specific occurrence of a close molecular neighbor-
hood, most likely because of the high protein concentration at
the plasma membrane. An additional FRET analysis for
5-HT7R-CFP and CD44-YFP performed at a fixed donor/
acceptor ratio showed no correlation with the expression level
(Figure S3A). In other words, the FRET efficiencies were inde-
pendent of donor/acceptor concentrations, thus confirming a
specific, as opposed to random, interaction between the two
proteins (James et al., 2006).
These combined data demonstrate an interaction between
5-HT7Rs and CD44 in the nanodomain on the scale of minutes.
Intriguingly, this interaction occurs independently of the 5-HT7R
activation/inactivation because neither agonist nor antagonist
alter the EfDA value (Figure S3B).
Endogenous 5-HT7Rs and CD44 Form a Protein
Complex in the Mouse Brain
We next asked whether the endogenous 5-HT7Rs and CD44
interact to form a protein complex. Because the expression of
5-HT7Rs peaks during early postnatal stages (Kobe et al.,
2012), we analyzed whole-brain lysates prepared from wild-
type (WT) and 5-HT7R-deficient mice at post-natal day 6 (P6)
by coIP. These experiments demonstrated a direct interaction
of endogenous CD44 and the 5-HT7R (Figure 4A; Figure S4A).
A possibility for interaction of CD44 and 5-HT7R at the cellular
level was verified by immunofluorescence analysis performed
in cultures of dissociated hippocampal neurons using antibodies
against the 5-HT7R, CD44, and synaptophysin, which was used
as a presynaptic marker (Kobe et al., 2012). The 5-HT7R was co-
localized with CD44 at synapses (Figure 4B). The specificity of
the anti-5-HT7R antibody was verified using neurons transfected
with the shRNA against 5-HT7R (Figure S4B).
To verify co-localization of endogenous 5-HT7Rs and CD44
during development in situ, immunohistochemistry was per-
formed in hippocampal slices prepared from 6-day-old and
8-month-old mice. 5-HT7Rs and CD44 were highly co-localized
in the CA1, CA2, and CA3 regions and the dentate gyrus of the
hippocampus in P6 mice (Figure 4C). Consistent with our previ-
ous observations (Kobe et al., 2012), the expression of theFigure 4. Interaction between Endogenous 5-HT7R and CD44 in the B
(A) CoIP between 5-HT7R and CD44 in brain lysates. Whole-brain homogenates
without antibody (w/o Ab), followed byWBanalysis with anti-5-HT7R and anti-CD4
of proteins after IP. Results are representative of at least four independent exper
(B) Co-localization of 5-HT7R, synaptophysin, and CD44 in primary hippocampal
antibodies, and analyzed for expression of 5-HT7R, CD44, and the synaptic mar
(red), CD44 (green), and synaptophysin (blue) of a representative neuron. Bottom:
Figure S4B.
(C) Co-localization of 5-HT7R and CD44 in hippocampal slices. Brain slices from
the detection of 5-HT7R (red) and CD44 (green), followed by confocal microscop5-HT7R was drastically downregulated in the hippocampus in
8-month-old mice (Figure 4C), whereas changes in CD44
expression were less prominent.
Stimulation of 5-HT7Rs Leads to MMP-9 Activation
To test whether 5-HT7R stimulation activates MMP-9, we used
three different approaches: visualization of gelatinase (MMP-9
and MMP-2) activity at the single-spine level in living cells, anal-
ysis of total MMP-9 activity via gel zymography, and ratiometric
measurements using a FRET-based MMP-9 activity biosensor.
In the first approach, hippocampal neurons visualized by
RFP expression were pre-incubated with the fluorogenic sub-
strate dye-quenched (DQ)-gelatin. Upon 5-CT application, we
observed significantly enhanced gelatinase activity in dendrites
of WT neurons, particularly at the newly elongated dendritic
spines (Figure 5A, white arrows). In contrast, in cells that were
either pretreated with the highly selective 5-HT7R antagonist
SB 269970 (10 min) or isolated from 5-HT7R KO mice or
MMP-9 KOmice, 5-CT treatment had no effect on gelatinase ac-
tivity (Figures 5A and 5B).
In the second approach, total MMP-9 activity was evaluated
using gel zymography (Vandooren et al., 2013). We found that
5-CT application significantly increased MMP-9 activity 20 min
post-stimulus compared with the control samples, whereas
constitutive receptor activity (which was verified by treatment
with the receptor antagonist SB 269970) was not involved in
MMP-9 activation (Figures 5C and 5D). Again, pretreatment
with the 5-HT7R antagonist SB 269970 or using cells from
5-HT7R KO mice completely abolished the effect of 5-CT and
dropped MMP9 activity to the levels seen in control experiments
(Figures 5C and 5D; Figure S5).
To evaluate the 5-HT7R-mediated activation of MMP-9 in real
time, live-cell imaging was performed in hippocampal neurons
transfectedwith the FRET-basedMMP-9 activity biosensor (Sta-
warski et al., 2014b). In this construct, MMP-9 activation can be
monitored by observing a decrease of the Venus/mTFP1 fluores-
cence intensity ratio mediated by MMP-9 sensor cleavage (Fig-
ure S6A). To verify the sensor’s responsiveness, WT neurons
were treated with aaMMP-9, resulting in cleavage of the
biosensor (Figure 5E) and a significant reduction in the Venus/
mTFP1 fluorescence intensity ratio relative to control cells (Fig-
ures 5F and 5G). 5-CT treatment of sensor-expressing WT neu-
rons also resulted in a significant decrease in the Venus/mTFP1
fluorescence intensity ratio (Figures 5E–5G). In contrast, pre-in-
cubation of 5-HT7Rs with SB 269970 abolished the effect of
5-CT on biosensor cleavage (Figure 5E–5G), indicating the
importance of 5-HT7R for activation of endogenous MMP-9.rain
were prepared from P6 mice and subjected to IP with anti-5-HT7R antibody or
4 antibodies. Top: the expression of proteins before IP. Bottom: the expression
iments. For control of the specificity of anti-5-HT7R antibody, see Figure S4A.
neurons. Neurons were fixed on day in vitro 12 (DIV12), incubated with specific
ker synaptophysin using confocal microscopy. Top: the expression of 5-HT7R
merged image and a magnified view of two representative dendrites. See also
6-day-old and 8-month-old mice were subjected to immunohistochemistry for
y.
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This was further confirmed by the observation that no cleavage
of the MMP-9 activity biosensor was found upon 5-CT applica-
tion in neurons isolated from 5-HT7R KO mice (Figures 5F and
5G; Figure S6B). To determine whether the MMP-9 biosensor
can still be cleaved in 5-HT7R KO neurons, these cells were
treated with aaMMP-9, resulting in a significant decrease in the
Venus/mTFP1 fluorescence intensity ratio (Figures 5F and 5G).
MMP-9 Cleaves the Extracellular Domain of CD44
It has been shown that CD44 can be proteolytically cleaved at
the ectodomain through membrane-anchored metalloproteases
and that CD44 cleavage plays a critical role in the regulation of
cellular morphology (Okamoto et al., 1999). Having demon-
strated that 5-HT7R stimulation leads to MMP-9 activation, we
asked whether CD44 is a cleavage substrate of MMP-9. For
that, homogenates were prepared from hippocampal tissue
from P6 mice and incubated with recombinant aaMMP-9
(400 ng/mL). Western blot analysis revealed an increase in
both the 40- and 55-kDa cleavage products of CD44, identified
with an antibody directed against the extracellular domain of
CD44, and a 25-kDa protein band that was recognized by an
antibody against the intracellular domain (Figure S7A). These
data suggest that CD44 might be a substrate for MMP-9 in the
brain. As a positive control for MMP-9 activity, we used b-dystro-
glycan, a well-establishedMMP-9 substrate (Figure S7A; Micha-
luk et al., 2007). To investigate the MMP-9-mediated proteolytic
cleavage of CD44 in molecular detail, hippocampal neurons
were transfected with the CD44 shedding reporter, which en-
ables the visualization of CD44 cleavage in living cells (Mar-
rero-Diaz et al., 2009). In this construct, CD44 is fused to
mOrange at the N terminus and GFP at the C terminus. After
cleavage of the extracellular domain of CD44, mOrange is
released, resulting in a decrease in the mOrange/GFP fluores-
cence intensity ratio (Figure S7B). After 20-min aaMMP-9 treat-
ment of WT neurons expressing the CD44 shedding reporter,
we observed a significant decrease in themOrange/GFP fluores-
cence intensity ratio compared with controls (Figures S7C andFigure 5. Stimulation of 5-HT7Rs Increases the Activity of MMP-9 on E
(A) Time-lapse images of dendrites before and 20 min after 5-CT treatment. Th
dendritic spines 20 min after 5-CT treatment in WT neurons (white arrows). The
(B) Quantification of gelatinase activity on dendritic spines. Intensities are present
in a significant increase in gelatinase activity, whereas SB269970 (0.99 ± 0.01, nc
gelatinase activity. 5-CT stimulation of neurons from 5-HT7R KOmice andMMP-9
p = 0.8, ncell = 24; MMP-9 KO, 1.02 ± 0.02, p = 0.4, ncell = 18; **p < 0.01, ***p < 0
(C) Gelatinase activity of hippocampal neurons exposed to 5-CT for 20 min. A re
(D) Quantification of the MMP-9/MMP-2 activity ratio in the zymogram shown in (C
n = 16). The MMP-9/MMP-2 ratio did not change in cells treated with SB 269970 (1
as in neurons isolated from KO 5-HT7R mice upon 5-CT stimulation. All data are
(E) Live-cell imaging of FRET-based MMP-9 activity biosensor (see also Figure
A representative image for each condition shows the mean Venus/mTFP1 fluor
interest is shown as the mean intensity ratio before and after treatment (see also
(F) The representative time courses of the normalized Venus/mTFP1 fluorescence
treatment is indicated by the arrow.
(G) Quantification of normalized fluorescence intensity ratios of WT and 5-HT7
aaMMP-9 results in significant reduction in the Venus/mTFP1 fluorescence intens
5-CT treatment of WT neurons significantly decreases the Venus/mTFP1 fluores
269970 abolished this effect (101.9% ± 0.49%). No changes in Venus/mTFP1
neurons (101.0% ± 0.67% for 5-CT treatment versus 100.5% ± 0.16% for cont
Venus/mTFP1 ratio to 94.3% ± 0.93% (p < 0.001). The data are expressed as thS7D). Treatment with an inactive mutant of MMP-9 (iaMMP-9)
did not induce any changes in the mOrange/GFP ratio (Figures
S7C and S7D). These combined data suggest that MMP-9 can
proteolytically cleave CD44 at its extracellular domain.
Stimulation of 5-HT7RsLeads toMMP-9-MediatedCD44
Cleavage
To understand whether 5-HT7R activation leads to CD44 cleav-
age and whether this process occurs in an MMP-9-dependent
manner, we performed time-lapse analysis of the cleavage of
the CD44 shedding reporter in WT neurons and neurons isolated
from 5-HT7R KO and MMP-9 KO mice. Application of 5-CT re-
sulted in profound cleavage of the CD44 shedding reporter, as
assessed by a decreased mOrange/GFP fluorescence intensity
ratio (Figure 6A), an effect similar to that obtained after
aaMMP-9 application (Figures S7C and S7D). Importantly, pre-
treatment with either the 5-HT7R antagonist SB 269970
(10 min) or the specific inhibitor of MMP-9 enzymatic activity in-
hibitor I (30 min) reduced the cleavage of CD44 to the baseline
level (Figures 6A and 6B). Noteworthy is that 5-CT treatment of
neurons isolated from either 5-HT7R KO or MMP-9 KO mice
had no effect on CD44 cleavage (Figure 6). At the same time,
cleavage of CD44 was still observed in both KO 5-HT7R neurons
and KO MMP-9 neurons upon aaMPP-9 application (Figure 6A),
thus ruling out concomitant effects pertinent to the knockout
models. In summary, these results strongly indicate that stimula-
tion of the 5-HT7R leads to CD44 cleavage in neurons in an
MMP-9-dependent manner.
The 5-HT7R/MMP-9/CD44 Signaling Cascade
Contributes to the Expression of LTP
Our previous study revealed an impairment of CA1 LTP after acti-
vation of the 5-HT7R by 5-CT in organotypic hippocampal
cultures (Kobe et al., 2012). Here we found a similar effect at
CA3-CA1 synapses in acute hippocampal slices (Figure 7A)
and sought to investigate the roles of MMP-9 (extracellular part)
and Cdc42 (intracellular part) in the underlying mechanisms.longating Dendritic Spines
e co-localization map shows an increase in gelatinase activity at elongating
color-coded bar indicates the percentage of co-localization.
ed relative to controls. 5-CT treatment (1.19 ± 0.04, p < 0.001, ncell = 24) results
ell = 18) and SB269970 + 5-CT treatment (1.01 ± 0.04, ncell = 21) did not change
KOmice did not induce changes in gelatinase activity (5-HT7 KO, 1.03 ± 0.02,
.001).
presentative gel zymogram is shown (see also Figure S5).
) after 5-CT treatment revealed a significant increase (1.47 ± 0.06, p < 0.0001,
.02 ± 0.10, n = 5) or treated with SB 269970 + 5-CT (0.89 ± 0.05, n = 13) as well
expressed as mean ± SEM. ***p < 0.001.
S6A) after treatment with aaMMP-9, 5-CT, or 5-CT + SB 269970 for 20 min.
escence intensity ratio before treatment. The magnified view of the region of
Figure S6B).
intensity ratio are depicted for the indicated regions of interest. The time point of
R KO neurons after the indicated treatments. Treatment of WT neurons with
ity ratio to 92.8% ± 0.41% (p < 0.001) relative to control cells (101.2% ± 1.45%).
cence intensity ratio to 96.0% ± 0.58% (p < 0.001), and pretreatment with SB
fluorescence intensity ratio were found upon 5-CT application in 5-HT7R KO
rol), whereas treatment with aaMMP-9 results in a significant decrease in the
e mean ± SEM of different cells (nR 3, ***p < 0.001, ANOVA).
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Figure 6. 5-HT7R Stimulation Leads to
MMP-9-Dependent Cleavage of CD44
(A) Representative images of living neurons ex-
pressing the CD44 shedding reporter are shown as
the mOrange/GFP fluorescence intensity ratio.
5-CT treatment results in a decrease in the
mOrange/GFP fluorescence intensity ratio. Under
control conditions and in cells that were pre-incu-
bated with SB 269970 or MMP-9 inhibitor I, no
changes in the mOrange/GFP fluorescence in-
tensity ratio were observed. 5-CT stimulation of
neurons isolated from 5-HT7R KO and MMP-9 KO
mice did not result in any changes in the mOrange/
GFP fluorescence intensity ratio. aaMMP-9 treat-
ment of neurons isolated from 5-HT7R KO mice
andMMP-9 KOmice decreased themOrange/GFP
fluorescence intensity ratio.
(B) Quantification of the mOrange/GFP fluores-
cence intensity ratio 20 min after treatment with
5-CT, SB 269970 + 5-CT, and inhibitor I + 5-CT
relative to controls. (5-CT, 0.885 ± 0.027 [ncell = 15];
SB 269970, 1.022 ± 0.024 [ncell = 23]; inhibitor I,
1.001 ± 0.020 [ncell = 14]). 5-CT stimulation of
neurons isolated from 5-HT7R KO mice (1.010 ±
0.010, ncell = 13) and MMP-9 KO mice (0.990 ±
0.019, ncell = 17) did not change the mOrange/GFP
ratio. After treatment with aaMMP-9, a significant
decrease in the mOrange/GFP ratio was observed
at 20 min in neurons from both 5-HT7R KO mice
(0.856 ± 0.009, ncell = 15) and MMP-9 KO mice
(0.846 ± 0.034, ncell = 10). The data are expressed
as mean ± SEM (*p < 0.05, **p < 0.01, ***p < 0.001,
Student’s t test).
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Application of 5-CT reduced LTP from 129.6% ± 4.0% to
111.4% ± 4.2% (p < 0.01), whereas the effect of 5-CT was
completely blocked in the presence of MMP-9 inhibitor I (LTP at
123.8% ± 2.8%; Figures 7A and 7C). Similarly, co-application
of the Cdc42 inhibitor ZCL 278 blocked the 5-CT-associated
LTP impairment (LTP at 127.8% ± 9.6%; Figures 7B and 7D).
These data suggest that 5-HT7R-mediated activation of
MMP-9 and Cdc42 are required for the inhibitory effect of 5-CT
on LTP.
To examine whether 5-CT mediated LTP reduction correlates
with the proteolytic cleavage of endogenous CD44 via MMP-9,
hippocampal slices were subjected to western blot analysis after
5-CT stimulation. We separately verified the amount of un-
cleaved CD44 in the membrane fraction and the amount of
55-kD cleaved CD44 fragment in the extracellular fraction. In
slices incubated with 5-CT, we observed accumulation of the
55-kDa cleavage products of CD44 identified with the antibody
against the extracellular domain of CD44 in the soluble fraction
and a decrease of full-length CD44 in the membrane fraction
(Figures 7E and 7F). Pretreatment of the sliceswithMMP-9 inhib-
itor I reduced the cleavage of CD44 to baseline level.
DISCUSSION
Since the turn of the millennium, the ECM and extracellular pro-
teases arose as important regulators of synaptic plasticity (Ditya-
tev et al., 2010; Wlodarczyk et al., 2011). We have recently
demonstrated that 5-HT7R-mediated signaling also influences
neuronal morphology, synaptogenesis, and synaptic plasticity
(Kvachnina et al., 2005; Kobe et al., 2012). However, the possible
interplay between these signaling pathways has not yet been
studied. Here we have shown that the coordinated interplay be-
tween 5-HT7R, MMP-9, and CD44 contributes to changes in
dendritic spine morphology and affects LTP.
The specific interaction between 5-HT7Rs and CD44 may
imply their involvement in the common signaling pathways.
5-HT7Rs are coupled to two different heterotrimeric G-proteins,
GaS and Ga12, and we have previously shown that the receptor-
mediated activation of Ga12 protein results in the selective acti-
vation of the small GTPase Cdc42, which, in turn, promotes the
formation of dendritic spines and synaptogenesis (Kvachnina
et al., 2005; Kobe et al., 2012). CD44-mediated signaling has
also been shown to influence the function of small Rho GTPases
in cancer cells (for a review, see Bourguignon, 2008). Both CD44
and Cdc42 are physically linked to IQGAP1 in tumor cells (Bour-
guignon et al., 2005), and a complex that consists of CD44,
Cdc42, and IQGAP1 is able to bind the actin cytoskeleton,
thereby regulating actin rearrangement (Briggs and Sacks,
2003). Moreover, CD44-mediated signaling has been shown to
stimulate both the Cdc42-CD44 association and PAK1 phos-
phorylation, leading to the modulation of ovarian tumor cell
growth and migration (Bourguignon et al., 2007). A similar inter-
action between CD44 and Cdc42 might also occur in neurons, in
which we observed a high level of expression of CD44 (Figure 4).
Functionally, CD44 interaction with 5-HT7Rs can serve as a
signal integrator regulating Cdc42 activity toward themodulation
of spine morphology. This is supported by the observation that
both knockdown of CD44 as well as pharmacological inhibitionof Cdc42 result in abolished 5-HT7R-mediated spine elongation
(Figure 1).
Using gel zymography, a DQ-gelatin assay (Szepesi et al.,
2014), and the MMP-9 biosensor (Stawarski et al., 2014b), we
also demonstrated that 5-HT7R-mediated signaling facilitates
the enzymatic activity of MMP-9 in primary hippocampal cul-
tures. Concomitantly with measuring gelatinase (MMP-9 and
MMP-2) activity, we assayed spine morphology by monitoring
the length and head width of individual spines that were targeted
by 5-HT7R stimulation in live hippocampal neurons. We found
that the changes in gelatinase activity were predominantly local-
ized to elongating spines. This is consistent with a previous
observation where MMP-9 activity upon synaptic potentiation
localized only to subpopulations of small dendritic spines (Sze-
pesi et al., 2014). Experiments with the MMP-9 biosensor
confirmed the increase in MMP-9 activity upon the agonist-
dependent activation of 5-HT7Rs. However, the mechanism re-
mains elusive. As mentioned above, 5-HT7Rs are coupled to
GaS and Ga12. The Ga12 subunit is known to regulate gene
expression by transcriptional activation of distinct transcriptional
control elements, such as serum response element (SRE), via
activation of small GTPases of the Rho family (Fromm et al.,
1997; Mao et al., 1998). We also confirmed that activation of
the 5-HT7R/G12 signaling pathway results in Rho-dependent
activation of SRE (Kvachnina et al., 2005). Functionally, activa-
tion of SRE has been shown to be associated with transcription
of a variety of immediate-early genes, including the c-fos gene
(Chai and Tarnawski, 2002), which can bind to the proximal
MMP9 promoter region and upregulate the level of MMP-9 enzy-
matic activity (Kuzniewska et al., 2013).
In addition, MMP-9 can be activated by other mechanisms
that might be integrated with the serotonin transmission. It is
known that MMP-9 activity can be induced through LTP (Nagy
et al., 2006) and that MMP-9 mRNA can undergo quick local
translation to dendritic spines, where MMP-9 protein can be
released following glutamate stimulation (Dziembowska et al.,
2012). This process requires activation of extracellular signal-
regulated kinase1/2 (ERK1/2) (Kuzniewska et al., 2013). Thus,
5-HT7R may modulate MMP9 activity through Gs-mediated
ERK1/2 signaling. Our study shows a short-term MMP-9
response where the enhanced proteolytic activity is observed
20 min after 5-HT7R stimulation. This indicates that the increase
in MMP-9 activity upon receptor stimulation is more likely to be
caused by either an increase in local translation or release of pre-
viously synthesized MMP-9 rather than transcription regulation,
which is a longer process.
MMP-9 was previously shown to bind CD44 and dock close to
the membrane in cell lines (Yu and Stamenkovic, 2000; Orgaz
et al., 2014). In the present study, we provided direct evidence
that CD44 is a target of neuronal MMP-9 in both neuronal cul-
tures and the brain. Using a CD44 shedding reporter, we also
demonstrated fast CD44 cleavage upon 5-HT7R stimulation in
an MMP-9-dependent manner.
From the functional point of view, CD44 processing is impli-
cated in the modulation of intracellular signaling and mor-
phology. The extracellular cleavage of CD44 results in disruption
of cell-matrix interaction, which, in turn, might facilitate the for-
mation of new protrusions. Furthermore, soluble CD44 acts asCell Reports 19, 1767–1782, May 30, 2017 1777
Figure 7. LTP Depends on 5-HT7R/MMP-9/Cdc42 Signaling
(A–D) Application of 5-CT impaired LTP induced by high-frequency stimulation (HFS, indicated by arrows). LTP could be rescued by MMP-9 inhibitor I (A and C)
and the Cdc42 inhibitor ZCL 278 (B and D).
(C) Mean ± SEM of LTP levels measured in control slices, slices treated with 5-CT and with Inhibitor I in combination with 5-CT (n = 7, **p < 0.01, *p < 0.05).
(D) Mean ± SEM of LTP levels measured in control slices, slices treated with 5-CT and with Cdc42 inhibitor ZCL in combination with 5-CT (n = 7, *p < 0.05).
(legend continued on next page)
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a competitor of endogenous hyaluronan, thus further contrib-
uting to detachment of the cell from the ECM (Cichy and Pure´,
2003). The intracellular fragment of CD44 has been reported to
translocate to the cell nucleus after cleavage and bind to a
response element that induces expression of the MMP-9 gene
(Miletti-Gonza´lez et al., 2012). Importantly, CD44 and Cdc42
interaction was previously reported (Briggs and Sacks, 2003),
implying an influence of CD44 processing on cytoskeleton re-
modeling and, consequently, dendritic spine morphology. The
functional importance of 5-HT7R/MMP-9-mediated processing
of CD44 was further supported by the fact that treatment of hip-
pocampal slices with 5-CT resulted in MMP-9-dependent accu-
mulation of 55-kDa cleavage products of CD44, which was
accompanied by impaired LTP impairment in the Schaffer collat-
eral synapses (Figure 7). Previous studies revealed that MMP-9
inhibitors impair the late phase of CA1 LTP but have no effects
60 min after induction of LTP (Nagy et al., 2006), whereas this
phase of LTP is impaired in MMP-9-overexpressing rats (Mag-
nowska et al., 2016). In line with these data, MMP-9 inhibitor I
did not affect CA1 LTP 60 min after induction of LTP but rescued
the defect in LTP induced by 5-CT (Figure 7), supporting the view
that stimulation of the 5-HT7R activates MMP-9 and that hyper-
activity of MMP-9 impairs LTP. In addition, a recent report re-
vealed that postnatal forebrain deletion of Cdc42 leads to
impaired LTP in the Schaffer collateral synapses (Kim et al.,
2014). Because our data demonstrate rescue of LTP by co-appli-
cation of 5-CT and the inhibitor of Cdc42 ZCL278, we suggest
that there is an optimal range of Cdc42 activity that promotes
LTP whereas Cdc42 deficit or hyperactivity impairs it.
5-HT7R KO mice show impaired contextual fear conditioning
and reduced CA1 LTP but no significant deficits in motor and
spatial learning or cued and operant conditioning (Roberts
et al., 2004). A more recent work also demonstrated a normal
learning curve in 5-HT7R KO mice and even better spatial mem-
ory retention in a Barnes maze (a longer time in the target area
1 month after training) (Sarkisyan and Hedlund, 2009). Thus,
the hippocampus-dependent behaviors and CA1 LTP appeared
to have bell-shaped dependence on the activity of 5-HT7R, so
the lack or excess of activity leads to impaired function. We
already made a similar conclusion in respect to Cdc42, the
effector downstream of 5-HT7R. Moreover, we hypothesize
that morphogenic effects mediated by the 5-HT7Rs, although
reducing functional processes underlying re-consolidation of es-
tablished memories, can be particularly beneficial in the context
of reversal learning and cognitive flexibility (Marin and Dityatev,
2017). Indeed, 5-HT7R KO mice are worse in reversal learning
in a Barnes maze (Sarkisyan and Hedlund, 2009), and genetic
or enzymatic attenuation of the ECM promotes reversal learning
in multiple behavioral paradigms (Morellini et al., 2010; Happel
et al., 2014). On the other hand, it is known that 5-HT7R KO
mice spend less time in rapid eye movement sleep than their
WT counterparts (Monti and Jantos, 2014). This may have anValues obtained in (C) and (D) were measured as average slope of EPSPs record
(E) Western blot analysis of CD44 cleavage in membrane and soluble fractions in c
with 5-CT results in an increased amount of 55-kDa cleavage CD44 fragment in
(F) Quantification of the ratio of 55-kDa CD44 in the soluble fraction over full-len
I-treated hippocampal slices. Glyceraldehyde-3-phosphate dehydrogenase (GAeffect on memory consolidation and, hence, lead to cognitive
impairment independent of the mechanism we have studied.
Further behavioral studies are warranted to verify the role of
5-HT7R-controlled proteolysis of CD44 in these aspects of
learning and memory (re)consolidation.
Altogether, our data demonstrate that components of the
5-HT7R/Cdc42 signaling pathway, together with CD44 and
MMP-9, belong to the same signaling module, which may be
responsible for regulating neuronal morphology and plasticity
(Figure S8). In this cascade, stimulation of the 5-HT7R results
in MMP-9 activation, which, in turn, modulates the activity of
CD44 through the proteolytic cleavage of its extracellular
domain. This leads to disinhibition of the small GTPase Cdc42,
which then becomes more accessible for 5-HT7R-mediated
activation. CD44 cleavage also results in partial detachment of
the target cell from the ECM, thus facilitating morphological
changes mediated by 5-HT7R/Cdc42 signaling. Finally, demon-
stration of the specific activation of MMP-9 in response to the
stimulation of 5-HT7R elucidates a possible role of both
MMP-9 and 5-HT7 proteins in establishing pathophysiological
conditions, pointing out the 5-HT7R/MMP-9/CD44 signaling
module as a target for the treatment of depression and anxiety
disorders.
EXPERIMENTAL PROCEDURES
Animals
The experiments were performedwith brains fromWT,MMP-9-KO (Ducharme
et al., 2000), and 5-HT7R KO (Hedlund et al., 2003) mice. All procedures per-
formed on animals were in accordance with the guidelines of the First Warsaw
Ethical Committee on Animal Research (permission no. 554/2013).
Cell Culture and Transfection
Mouse N1E-115 neuroblastoma cells from the American Type Culture
Collection were grown in DMEM (Gibco) that contained 10% fetal calf serum
(FCS, Gibco) and penicillin/streptomycin (100 U/mL, Gibco) at 37C under
5% CO2. Transient transfection was performed with Lipofectamine 2000
(Invitrogen) according to the manufacturer’s instructions.
Preparation, Transfection, and Treatment of Hippocampal Neurons
Mouse primary hippocampal neurons were prepared as described previously
(Kobe et al., 2012). Rat hippocampal organotypic slices were prepared
according to Stoppini et al. (1991). See the Supplemental Experimental Pro-
cedures for details and treatments.
Immunofluorescence
For experimental details and a list of antibodies and usage, see the Supple-
mental Experimental Procedures.
Live-Cell Imaging
Prior to imaging, the cells were mounted in an acquisition chamber. The
osmolality of the buffer was adjusted to the osmolality (± 15 mOsm) of the
maintenance medium. Images were acquired using a Zeiss LSM 780 confocal
microscope with a long distance (LD) C-Apochromat 403/1.1 W Korr M27
water immersion objective. For experimental details, see the Supplemental
Experimental Procedures.ed 50–60 min after HFS relative to the average slope of baseline fEPSPs.
ontrol and 5-CT- and 5-CT + inhibitor I-treated hippocampal slices. Treatment
soluble fraction and a decrease in full-length CD44 in the membrane fraction.
gth CD44 in the membrane fraction in control and 5-CT- and 5-CT + inhibitor
PDH) was used as a calibrator.
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Biochemical Methods
Standard methodologies for coIP, western blotting, and gel zymography were
used. For experimental details and a list of antibodies and usage, see the Sup-
plemental Experimental Procedures.
Electrophysiology
For experimental details, see the Supplemental Experimental Procedures.
Two-Photon Excitation Imaging and Uncaging
For experimental details, see the Supplemental Experimental Procedures.
Statistical Analysis
For details, see the Supplemental Experimental Procedures.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and eight figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2017.05.023.
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